(English) Future Pharm Announces the Release of HEMPLETS™

PHOENIX, Aug. 4, 2020 /PRNewswire-PRWeb/ — Future Pharm recently released its latest product, HEMPLETS™. HEMPLETS™ is the only liposomal chewable tablet in the world that has a patent pending liposome platform. It is designed to have an average particle distribution of 165 Nano meters, increases oral absorbance and bioavailability. HEMPLETS™ is designed to deliver a potent dose of CBD that is THC free in an oral tablet form unlike anything else. HEMPLETS™ is a highly advanced technology in a…